Skin conditions (dermatitis, eczema, psoriasis) Board decisions

The Board denied all claims for increased ratings, finding that the evidence did not support a higher rating for any of the conditions.

The Board denied the veteran's claims for earlier effective dates for service connection and increased ratings, finding that the evidence did not support an earlier date than May 4, 2023.

The Board readjudicated the claims for service connection for bilateral hearing loss, a respiratory disability, and a skin disability based on new and relevant evidence. The claims for an acquired psychiatric disability, sleep impairment, hypertension, impaired vision, residual disability from vasectomy, and a compensable rating for scars were denied.

The Board remands the matter for further development, including obtaining a separation examination and an adequate medical opinion from a dermatologist or doctor.

The Veteran's attorney is not eligible for direct payment of attorney fees based on past-due benefits awarded in the November 2024 rating decision.

The Board dismissed the Veteran's claims for service connection and increased ratings due to improper concurrent election of multiple review options.

The Veteran's service-connected migraine headaches, along with other disabilities, have prevented her from obtaining and maintaining substantial and gainful employment, warranting an award of extraschedular TDIU and special monthly compensation at the housebound rate effective February 17, 2022.

The Board denied service connection for migraine headaches and a skin disability, to include dermatitis and psoriasis, as the evidence did not support a nexus between these conditions and the Veteran's military service.

The Board denied service connection for a skin disorder other than chloracne, to include as due to herbicide agent exposure.

The Board granted a 60 percent rating for bilateral lichen simplex/chronic dermatitis from February 19, 2015, to September 21, 2023.

The Board has reopened the claims for service connection for rib disorder, reflex sympathetic dystrophy, fibromyalgia, respiratory disorder, skin condition, to include psoriasis, bilateral hand arthritis, bilateral carpal tunnel syndrome, and bilateral ulnar neuropathy. However, the claims for service connection for bilateral hand arthritis, bilateral carpal tunnel syndrome, bilateral ulnar neuropathy, hypertension, rib disorder, reflex sympathetic dystrophy, fibromyalgia, respiratory disorder, and skin condition, to include psoriasis, have been denied.

The Board remands the claims for service connection for psoriasis, an initial compensable rating for hypertension, and a TDIU due to service-connected disabilities for further development.

The Board denied a compensable disability rating for pseudofolliculitis barbae as the Veteran's condition did not meet the criteria for a higher rating under the applicable diagnostic code.

The Board remands the claims for service connection for a respiratory disorder, claimed as asthma; a skin disorder, to include pseudofolliculitis barbae; erectile dysfunction; and a gastrointestinal disorder, claimed as GERD, for further development.

The Board granted service connection for diabetes mellitus type II as secondary to posttraumatic stress disorder with unspecified insomnia disorder and other service-connected disabilities, an effective date of March 8, 2022, for tinnitus, denied an earlier effective date prior to January 30, 2020, for sleep apnea, and granted a 30 percent rating for pseudofolliculitis barbae, effective August 27, 2019.

The Board denied service connection for bilateral tinea pedis, bilateral flat feet, and bilateral plantar fasciitis as the evidence did not support a finding that these conditions were incurred in or caused by military service.

The appeal was dismissed for untimeliness, and service connection claims were denied or remanded based on the evidence of record.

The Board remands the case for an aid and attendance examination to assess the Veteran's functional impairment due to his service-connected disabilities.

The Board remands the veteran's claims for further development and to obtain additional evidence.

The Board denied the Veteran's claims for initial compensable ratings for alopecia areata, cerumen impaction, pseudofolliculitis barbae (PFB), and hypertension.